DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

Data Compilation
#PharmaFlow

Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

Stock Recap
#PipelineProspector

IMIPRAMINE PAMOATE

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 9 USDMF, 2 EU WC, 1 NDC API, 2 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

1 Drugs in Development

1 Drugs in Development

INTERMEDIATES

3 API Suppliers

3 API Suppliers

FINISHED DOSAGE FORMULATIONS

26 FDF Dossiers, 16 FDA Orange Book, 2 Europe, 3 Australia, 2 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 150MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - EQ 75MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 SPI Pharma, 8 DKSH, 7 Gangwal Healthcare, 4 ACG Worldwide, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 5 BASF, 1 DFE Pharma, 3 Gangwal Chemicals, 3 Ingredion Pharma Solutions, 1 Kerry, 3 Lonza Capsugel, 5 Microlex e.U, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 2 Prachin Chemical, 1 Qualicaps, 10 Roquette, 1 Seppic, 2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 3 Sigachi Industries, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

24 Fillers, Diluents & Binders, 15 Lubricants & Glidants, 13 Disintegrants & Superdisintegrants, 12 Direct Compression, 9 Thickeners and Stabilizers, 9 Coating Systems & Additives, 8 Empty Capsules, 6 Taste Masking, 6 Co-Processed Excipients, 5 Granulation, 4 Controlled & Modified Release, 3 Emulsifying Agents, 3 Film Formers & Plasticizers, 3 Chewable & Orodispersible Aids, 3 Coloring Agents, 1 API Stability Enhancers, 1 Topical, 1 Surfactant & Foaming Agents

DIGITAL CONTENT

6 NEWS #PharmaBuzz

6 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 2 Finished Drug Prices

MARKET PLACE

2 APIs

2 APIs

REF. STANDARDS & IMPURITIES

1 USP, 1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
28/10/2024	Corden Pharma Bergamo S.p.A	Italy	FARCHEMIA SRL	23076	IMIPRAMINE PAMOATE	2009-08-26	Inactive	II	N/A
28/10/2024	H. Lundbeck AS	Denmark	LUNDBECK PHARMACEUTICALS ITALY SPA	22104	IMIPRAMINE PAMOATE	2008-10-15	Active	II	N/A

IMIPRAMINE PAMOATE

IMIPRAMINE PAMOATE

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers

9 USDMF

2 EU WC

1 NDC API

2 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

1 Drugs in Development

INTERMEDIATES

3 API Suppliers

FINISHED DOSAGE FORMULATIONS

26 FDF Dossiers

16 FDA Orange Book

2 Europe

3 Australia

2 South Africa

3 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 125MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 150MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - EQ 75MG HYDROCHLORIDE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

3 SPI Pharma

8 DKSH

7 Gangwal Healthcare

4 ACG Worldwide

1 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

5 BASF

1 DFE Pharma

3 Gangwal Chemicals

3 Ingredion Pharma Solutions

1 Kerry

3 Lonza Capsugel

5 Microlex e.U

1 Pharmatrans-Sanaq

3 Pluviaendo

2 Prachin Chemical

1 Qualicaps

10 Roquette

1 Seppic

2 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

3 Sigachi Industries

2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

24 Fillers, Diluents & Binders

15 Lubricants & Glidants

13 Disintegrants & Superdisintegrants

12 Direct Compression

9 Thickeners and Stabilizers

9 Coating Systems & Additives

8 Empty Capsules

6 Taste Masking

6 Co-Processed Excipients

5 Granulation

4 Controlled & Modified Release

3 Emulsifying Agents

3 Film Formers & Plasticizers

3 Chewable & Orodispersible Aids

3 Coloring Agents

1 API Stability Enhancers

1 Topical

1 Surfactant & Foaming Agents

DIGITAL CONTENT

6 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

2 Finished Drug Prices

MARKET PLACE

2 APIs

REF. STANDARDS & IMPURITIES

1 USP

CAPSULE;ORAL - EQ 100MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 125MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 150MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE;ORAL - EQ 75MG HYDROCHLORIDE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons